Table 1. Studies of potency test of HS vaccine (P-52), before passage in calf (natural host) from June 12 to June 18, 2008.
Vaccinated group | Culture dilute | Mortality | Dead | Survive | Accumulated value |
Mortality ratio | Percentage of mortality | |
Dead | Survive | |||||||
A1 | 10−1 | 3/5 | 3 | 2 | 16 | 2 | 16/18 | 88.88 |
A2 | 10−2 | 4/5 | 4 | 1 | 13 | 3 | 13/16 | 81.25 |
A3 | 10−3 | 3/5 | 3 | 2 | 9 | 5 | 9/14 | 64.24 |
A4 | 10−4 | 4/5 | 4 | 1 | 6 | 6 | 6/12 | 50.00 |
A5 | 10−5 | 2/5 | 2 | 3 | 2 | 9 | 2/11 | 18.18 |
A6 | 10−6 | 0/5 | 0 | 5 | 0 | 14 | 0/14 | 00 |
A7 | 10−7 | 0/5 | 0 | 5 | 0 | 19 | 0/19 | 00 |
A8 | 10−8 | 0/5 | 0 | 5 | 0 | 24 | 0/24 | 00 |
A9 | 10−9 | 0/5 | 0 | 5 | 0 | 29 | 0/29 | 00 |
A10 | 10−10 | 0/5 | 0 | 5 | 0 | 34 | 0/34 | 00 |